|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,435.50 INR | -0.31% |
|
+1.79% | -1.43% |
EPS & Dividend: GlaxoSmithKline Pharmaceuticals Limited
| Fiscal Period: March | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|
| Dividend per Share 2 | 30 | 32 | 32 | 42 | 57 | 29.5 | 29.5 |
| Rate of return | 1.8% | 2.42% | 1.65% | 1.46% | 2.5% | 1.21% | 1.21% |
| EPS 2 | 100 | 36.05 | 34.83 | 54.76 | 61.15 | 67.98 | 77.28 |
| Distribution rate | 30% | 88.8% | 91.9% | 76.7% | 93.2% | 43.4% | 38.2% |
| Reference price 2 | 1,662.95 | 1,324.15 | 1,943.10 | 2,877.30 | 2,283.40 | 2,435.50 | 2,435.50 |
| Nbr of stocks (in thousands) | 169,406 | 169,406 | 169,406 | 169,406 | 169,406 | 169,406 | - |
| Announcement Date | 16/05/22 | 17/05/23 | 17/05/24 | 13/05/25 | 13/05/26 | - | - |
1INR in Million2INR
Estimates
Past dividends: GlaxoSmithKline Pharmaceuticals Limited
| 29/05/2026 | Ex-dividend date - 57 INR | 05:00 |
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | ||
|---|---|---|---|---|---|---|
 | 1.21% | 1.21% | 35.83x | 15.51x | - | |
| 0.57% | 0.63% | 34.92x | 21.06x | 12.63x | |
| 2.08% | 2.18% | 27.42x | 6.9x | 6.3x | |
| 2.76% | 2.92% | 30x | 1336.57x | 7.34x | |
| 2.97% | 3.05% | 17.98x | 6.66x | 4.45x | |
| 2.86% | 2.95% | 21.52x | 6.42x | 5.52x | |
| 1.94% | 2.04% | 21.56x | 5.04x | 4.53x | |
| 3.52% | 3.42% | 14.17x | 6.24x | 5.3x | |
| 2.78% | 2.93% | 23.77x | 18.24x | 6.31x | |
| 2.5% | 2.59% | -46.02x | 8.12x | 5.6x | |
| Average | 2.32% | 2.39% | 18.11x | 143.08x | 6.44x | |
| Weighted average by Cap. | 2% | 2.08% | 23.87x | 174.42x | 7.85x |
Year-on-year evolution of the Yield
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Estimates Revisions
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Annual Profit -
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
